A company with marine bio-material extraction technology based on salmon DNA
We are striving to lead the regenerative medicine and cosmeceutical raw material markets.
Creative Spirit of Inquiry
A challenging attitude for improving
production levels
Top-tier Products with Expertise
Producing pharmaceutical-grade raw
materials for a wide range of applications
Creating Innovative Future Value
Research and development of
next-generation PDRN technologies
Genocure has successfully overcome biological limitations through continuous challenges, securing higher PDRN
productivity than competitors. Based on this productivity, we are stably supplying pharmaceutical-grade
PDRN/PN and producing various finished products, such as medical devices, pharmaceuticals, and cosmeceuticals.
Our ultimate goal is to rejuvenate humanity through our technology. We will open a new future by ensuring a stable supply of
raw materials by procuring return salmon and researching and developing new PDRN-related technologies.
As the 'Pink Penguin' of the global regenerative medicine and cosmeceutical market, we ask for your continued support
for the future that Genocure will create through PDRN. Thank you.
CEO, Oh Bo Kyung
-
11
·
Signing CDMO MSA with Asymchem China
-
05
·
Patent registration for PDRN/PN extraction and purification methods
·
World's first patent application for recombinant PDRN
·
Chuncheon bGMP Plant 1 concept design completed
-
04
·
Start of supply of PDRN/PN raw materials for cosmetics
-
03
·
Completion of development for Class II medical device wound dressings
-
01
·
Patent registration for enzyme hydrolysates of fish protein and its manufacturing method
-
11
·
Patent registration for mass extraction method of high-purity DNA (PN) from salmon flesh
·
Trademark registration for five technologies related to extracting DNA (PN) from salmon flesh (Sta-PN)
·
Trademark registration for five in-brand PDRN raw materials (CUREDNA)
-
08
·
Agreement signed for purchase of bGMP plant site
·
Establishment of Genocure Co., Ltd.